Kayne Anderson Capital Advisors LP bought a new stake in Exelon Co. (NASDAQ:EXC - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 183,844 shares of the company's stock, valued at approximately $7,455,000.
A number of other hedge funds have also modified their holdings of the business. Lazard Asset Management LLC boosted its position in shares of Exelon by 112.4% during the 1st quarter. Lazard Asset Management LLC now owns 31,527,396 shares of the company's stock worth $1,184,483,000 after acquiring an additional 16,686,526 shares in the last quarter. Los Angeles Capital Management LLC lifted its stake in Exelon by 666.2% during the second quarter. Los Angeles Capital Management LLC now owns 3,583,477 shares of the company's stock worth $124,024,000 after purchasing an additional 3,115,763 shares during the last quarter. Swedbank AB acquired a new position in Exelon in the first quarter valued at approximately $96,859,000. International Assets Investment Management LLC increased its stake in Exelon by 4,103.5% in the third quarter. International Assets Investment Management LLC now owns 1,046,630 shares of the company's stock valued at $42,441,000 after purchasing an additional 1,021,731 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. raised its holdings in Exelon by 101.8% during the third quarter. Robeco Institutional Asset Management B.V. now owns 1,344,978 shares of the company's stock worth $54,539,000 after purchasing an additional 678,490 shares in the last quarter. 80.92% of the stock is currently owned by hedge funds and other institutional investors.
Exelon Price Performance
Shares of NASDAQ:EXC traded up $0.50 during midday trading on Monday, hitting $39.23. 7,261,057 shares of the stock were exchanged, compared to its average volume of 6,758,581. The company has a current ratio of 1.09, a quick ratio of 0.97 and a debt-to-equity ratio of 1.66. The stock has a market cap of $39.42 billion, a P/E ratio of 16.14, a PEG ratio of 2.79 and a beta of 0.54. The company has a 50 day moving average price of $39.69 and a 200-day moving average price of $37.80. Exelon Co. has a twelve month low of $33.35 and a twelve month high of $41.42.
Exelon (NASDAQ:EXC - Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $0.71 EPS for the quarter, beating the consensus estimate of $0.67 by $0.04. Exelon had a return on equity of 9.47% and a net margin of 10.60%. The firm had revenue of $6.15 billion during the quarter, compared to analyst estimates of $5.85 billion. During the same period in the prior year, the firm posted $0.67 earnings per share. The business's quarterly revenue was up 2.9% compared to the same quarter last year. On average, research analysts forecast that Exelon Co. will post 2.45 earnings per share for the current year.
Exelon Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 13th. Investors of record on Monday, November 11th will be issued a $0.38 dividend. This represents a $1.52 dividend on an annualized basis and a yield of 3.87%. The ex-dividend date is Friday, November 8th. Exelon's dividend payout ratio is currently 62.55%.
Analysts Set New Price Targets
A number of equities research analysts recently weighed in on the stock. Barclays boosted their price target on shares of Exelon from $41.00 to $44.00 and gave the company an "overweight" rating in a research report on Tuesday, October 15th. UBS Group upped their target price on Exelon from $40.00 to $43.00 and gave the company a "neutral" rating in a research report on Friday, September 20th. Jefferies Financial Group initiated coverage on Exelon in a research report on Thursday, September 19th. They set a "buy" rating and a $46.00 price target on the stock. Wells Fargo & Company raised their target price on shares of Exelon from $40.00 to $42.00 and gave the stock an "equal weight" rating in a research report on Friday, August 2nd. Finally, Scotiabank upped their price target on shares of Exelon from $37.00 to $40.00 and gave the company a "sector perform" rating in a research report on Tuesday, August 20th. Eleven equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $41.33.
Get Our Latest Research Report on EXC
Exelon Company Profile
(
Free Report)
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
Read More
Before you consider Exelon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.
While Exelon currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.